Last Price
0.506
Today's Change
+0.006 (1.20%)
Day's Change
0.498 - 0.517
Trading Volume
949,610
Overview
Market Cap
184 Million
Shares Outstanding
361 Million
Avg Volume
15,325,924
Avg Price (50 Days)
0.51
Avg Price (200 Days)
1.17
PE Ratio
-0.81
EPS
-0.63
Earnings Announcement
30-Apr-2025
Previous Close
0.50
Open
0.50
Day's Range
0.498 - 0.5262
Year Range
0.28 - 2.45
Trading Volume
2,671,184
Price Change Highlight
1 Day Change
1.96%
5 Day Change
-1.26%
1 Month Change
40.36%
3 Month Change
-35.33%
6 Month Change
-73.86%
Ytd Change
-34.40%
1 Year Change
-70.19%
3 Year Change
-76.29%
5 Year Change
-73.99%
10 Year Change
-93.19%
Max Change
-99.61%
News and Blogs
No result.
Company Profile
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Latest Videos
.png)
Apps
Top Articles
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
